• Research & Development

  MGX292 Announced as PAH Therapy Candidate

  Posted by Pulmonary Hypertension News Moderator on December 5, 2018 at 1:12 pm

  Morphogen-IX recently announced that it will be further developing MGX292 as its treatment candidate for pulmonary arterial hypertension. Click here to read more.

  What do you think about this news?

  replied 7 years, 3 months ago 1 Member · 0 Replies
• 0 Replies

Log In to Reply